Archived News | Return to News Center

November 9, 2007

COP pharmacy awarded $150,000 to research brain cancer

The Children's Brain Tumor Foundation funds only three research projects each year. This year, one of those funded projects is from the University of Louisiana at Monroe College of Pharmacy.

Karen Briski, Ph.D. and department head of basic pharmaceutical sciences, was awarded a $150,000 grant for the project, “Novel Delivery Modes for Small Molecule Inhibitors of Medulloblastoma." She will attend a special reception in New York City on Nov. 13 to accept the award.

Medulloblastoma is the most common pediatric brain tumor for which no satisfactory treatments currently exist, Briski said.

“Due to the severe, long-term side effects of radiation and chemotherapy, new non-toxic, molecular-based approaches are urgently needed," said Briski. “Through this project, I believe we can make an important contribution to a significant problem.”

Briski's interdisciplinary research team has collective expertise in pharmaceutics, neuroscience, nanotechnology, X-ray fluorescence spectrometry, and toxicology. “I am always looking for the College of Pharmacy to engage in projects that enable the usage of interdisciplinary research. I believe major breakthroughs occur when a team-based approach is used," she said.

Her team includes:

The researchers will pursue the following objectives:

For additional information about this project, contact Briski at

PLEASE NOTE: Some links and e-mail addresses in these archived news stories may no longer work, and some content may include events which are no longer relevent, or reference individuals and/or organizations no longer associated with ULM.